Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
Fang Li,1Wenhui Li,3Michael Farzan,3Stephen C. Harrison1,2*
The spike protein (S) of SARS coronavirus (SARS-CoV) attachesthe virus to its cellular receptor, angiotensin-converting enzyme2 (ACE2). A defined receptor-binding domain (RBD) on S mediatesthis interaction. The crystal structure at 2.9 angstrom resolutionof the RBD bound with the peptidase domain of human ACE2 showsthat the RBD presents a gently concave surface, which cradlesthe N-terminal lobe of the peptidase. The atomic details atthe interface between the two proteins clarify the importanceof residue changes that facilitate efficient cross-species infectionand human-to-human transmission. The structure of the RBD suggestsways to make truncated disulfide-stabilized RBD variants foruse in the design of coronavirus vaccines.
1 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School and Laboratory of Molecular Medicine, 320 Longwood Avenue, Boston, MA 02115, USA. 2 Howard Hughes Medical Institute, Children's Hospital, 320 Longwood Avenue, Boston, MA 02115, USA. 3 Department of Microbiology and Molecular Genetics, Harvard Medical School, New England Primate Research Center, Southborough, MA 01772, USA.
* To whom correspondence should be addressed. E-mail: harrison{at}crystal.harvard.edu
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Kathryn V. Holmes (16 September 2005) Science309 (5742), 1822.
[DOI: 10.1126/science.1118817] |Summary »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Angiotensin-converting enzyme 2 (ACE2) from raccoon dog can serve as an efficient receptor for the spike protein of severe acute respiratory syndrome coronavirus.
L. Xu, Y. Zhang, Y. Liu, Z. Chen, H. Deng, Z. Ma, H. Wang, Z. Hu, and F. Deng (2009)
J. Gen. Virol.
90, 2695-2703
|Abstract »|Full Text »|PDF »
Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor {alpha}-converting enzyme.
M. Iwata, J. E. Silva Enciso, and B. H. Greenberg (2009)
Am J Physiol Cell Physiol
297, C1318-C1329
|Abstract »|Full Text »|PDF »
Proteolytic Activation of the Spike Protein at a Novel RRRR/S Motif Is Implicated in Furin-Dependent Entry, Syncytium Formation, and Infectivity of Coronavirus Infectious Bronchitis Virus in Cultured Cells.
Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia.
H. P. Jia, D. C. Look, P. Tan, L. Shi, M. Hickey, L. Gakhar, M. C. Chappell, C. Wohlford-Lenane, and P. B. McCray Jr (2009)
Am J Physiol Lung Cell Mol Physiol
297, L84-L96
|Abstract »|Full Text »|PDF »
Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice.
M. M. Becker, R. L. Graham, E. F. Donaldson, B. Rockx, A. C. Sims, T. Sheahan, R. J. Pickles, D. Corti, R. E. Johnston, R. S. Baric, et al. (2008)
PNAS
105, 19944-19949
|Abstract »|Full Text »|PDF »
Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies.
P. Guillon, M. Clement, V. Sebille, J.-G. Rivain, C.-F. Chou, N. Ruvoen-Clouet, and J. Le Pendu (2008)
Glycobiology
18, 1085-1093
|Abstract »|Full Text »|PDF »
Interaction of severe acute respiratory syndrome-coronavirus and NL63 coronavirus spike proteins with angiotensin converting enzyme-2.
A. C. Mathewson, A. Bishop, Y. Yao, F. Kemp, J. Ren, H. Chen, X. Xu, B. Berkhout, L. van der Hoek, and I. M. Jones (2008)
J. Gen. Virol.
89, 2741-2745
|Abstract »|Full Text »|PDF »
Pathways of Cross-Species Transmission of Synthetically Reconstructed Zoonotic Severe Acute Respiratory Syndrome Coronavirus.
T. Sheahan, B. Rockx, E. Donaldson, D. Corti, and R. Baric (2008)
J. Virol.
82, 8721-8732
|Abstract »|Full Text »|PDF »
Structural Analysis of Major Species Barriers between Humans and Palm Civets for Severe Acute Respiratory Syndrome Coronavirus Infections.
Mouse-Passaged Severe Acute Respiratory Syndrome-Associated Coronavirus Leads to Lethal Pulmonary Edema and Diffuse Alveolar Damage in Adult but Not Young Mice.
N. Nagata, N. Iwata, H. Hasegawa, S. Fukushi, A. Harashima, Y. Sato, M. Saijo, F. Taguchi, S. Morikawa, and T. Sata (2008)
Am. J. Pathol.
172, 1625-1637
|Abstract »|Full Text »|PDF »
Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction.
H.-X. Lin, Y. Feng, G. Wong, L. Wang, B. Li, X. Zhao, Y. Li, F. Smaill, and C. Zhang (2008)
J. Gen. Virol.
89, 1015-1024
|Abstract »|Full Text »|PDF »
Structural Basis for Potent Cross-Neutralizing Human Monoclonal Antibody Protection against Lethal Human and Zoonotic Severe Acute Respiratory Syndrome Coronavirus Challenge.
B. Rockx, D. Corti, E. Donaldson, T. Sheahan, K. Stadler, A. Lanzavecchia, and R. Baric (2008)
J. Virol.
82, 3220-3235
|Abstract »|Full Text »|PDF »
Mechanisms of Zoonotic Severe Acute Respiratory Syndrome Coronavirus Host Range Expansion in Human Airway Epithelium.
T. Sheahan, B. Rockx, E. Donaldson, A. Sims, R. Pickles, D. Corti, and R. Baric (2008)
J. Virol.
82, 2274-2285
|Abstract »|Full Text »|PDF »
Difference in Receptor Usage between Severe Acute Respiratory Syndrome (SARS) Coronavirus and SARS-Like Coronavirus of Bat Origin.
W. Ren, X. Qu, W. Li, Z. Han, M. Yu, P. Zhou, S.-Y. Zhang, L.-F. Wang, H. Deng, and Z. Shi (2008)
J. Virol.
82, 1899-1907
|Abstract »|Full Text »|PDF »
The Coronavirus Spike Protein Induces Endoplasmic Reticulum Stress and Upregulation of Intracellular Chemokine mRNA Concentrations.
G. A. Versteeg, P. S. van de Nes, P. J. Bredenbeek, and W. J. M. Spaan (2007)
J. Virol.
81, 10981-10990
|Abstract »|Full Text »|PDF »
Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection.
V. C. C. Cheng, S. K. P. Lau, P. C. Y. Woo, and K. Y. Yuen (2007)
Clin. Microbiol. Rev.
20, 660-694
|Abstract »|Full Text »|PDF »
Single Amino Acid Changes in the Nipah and Hendra Virus Attachment Glycoproteins Distinguish EphrinB2 from EphrinB3 Usage.
O. A. Negrete, D. Chu, H. C. Aguilar, and B. Lee (2007)
J. Virol.
81, 10804-10814
|Abstract »|Full Text »|PDF »
Amino Acid Substitutions in the S2 Region Enhance Severe Acute Respiratory Syndrome Coronavirus Infectivity in Rat Angiotensin-Converting Enzyme 2-Expressing Cells.
S. Fukushi, T. Mizutani, K. Sakai, M. Saijo, F. Taguchi, M. Yokoyama, I. Kurane, and S. Morikawa (2007)
J. Virol.
81, 10831-10834
|Abstract »|Full Text »|PDF »
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies.
Z. Zhu, S. Chakraborti, Y. He, A. Roberts, T. Sheahan, X. Xiao, L. E. Hensley, P. Prabakaran, B. Rockx, I. A. Sidorov, et al. (2007)
PNAS
104, 12123-12128
|Abstract »|Full Text »|PDF »
Synthetic Reconstruction of Zoonotic and Early Human Severe Acute Respiratory Syndrome Coronavirus Isolates That Produce Fatal Disease in Aged Mice.
B. Rockx, T. Sheahan, E. Donaldson, J. Harkema, A. Sims, M. Heise, R. Pickles, M. Cameron, D. Kelvin, and R. Baric (2007)
J. Virol.
81, 7410-7423
|Abstract »|Full Text »|PDF »
SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era.
Natural Mutations in the Receptor Binding Domain of Spike Glycoprotein Determine the Reactivity of Cross-Neutralization between Palm Civet Coronavirus and Severe Acute Respiratory Syndrome Coronavirus.
L. Liu, Q. Fang, F. Deng, H. Wang, C. E. Yi, L. Ba, W. Yu, R. D. Lin, T. Li, Z. Hu, et al. (2007)
J. Virol.
81, 4694-4700
|Abstract »|Full Text »|PDF »
Ribonucleocapsid Formation of Severe Acute Respiratory Syndrome Coronavirus through Molecular Action of the N-Terminal Domain of N Protein.
K. S. Saikatendu, J. S. Joseph, V. Subramanian, B. W. Neuman, M. J. Buchmeier, R. C. Stevens, and P. Kuhn (2007)
J. Virol.
81, 3913-3921
|Abstract »|Full Text »|PDF »
Participation of both Host and Virus Factors in Induction of Severe Acute Respiratory Syndrome (SARS) in F344 Rats Infected with SARS Coronavirus.
N. Nagata, N. Iwata, H. Hasegawa, S. Fukushi, M. Yokoyama, A. Harashima, Y. Sato, M. Saijo, S. Morikawa, and T. Sata (2007)
J. Virol.
81, 1848-1857
|Abstract »|Full Text »|PDF »
Mutational Analysis of Aminopeptidase N, a Receptor for Several Group 1 Coronaviruses, Identifies Key Determinants of Viral Host Range.
S. M. Tusell, S. A. Schittone, and K. V. Holmes (2007)
J. Virol.
81, 1261-1273
|Abstract »|Full Text »|PDF »
Structural Basis of Neutralization by a Human Anti-severe Acute Respiratory Syndrome Spike Protein Antibody, 80R.
W. C. Hwang, Y. Lin, E. Santelli, J. Sui, L. Jaroszewski, B. Stec, M. Farzan, W. A. Marasco, and R. C. Liddington (2006)
J. Biol. Chem.
281, 34610-34616
|Abstract »|Full Text »|PDF »
Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis..
W. Ren, W. Li, M. Yu, P. Hao, Y. Zhang, P. Zhou, S. Zhang, G. Zhao, Y. Zhong, S. Wang, et al. (2006)
J. Gen. Virol.
87, 3355-3359
|Abstract »|Full Text »|PDF »
Identifying Epitopes Responsible for Neutralizing Antibody and DC-SIGN Binding on the Spike Glycoprotein of the Severe Acute Respiratory Syndrome Coronavirus..
Y.-P. Shih, C.-Y. Chen, S.-J. Liu, K.-H. Chen, Y.-M. Lee, Y.-C. Chao, and Y.-M. A. Chen (2006)
J. Virol.
80, 10315-10324
|Abstract »|Full Text »|PDF »
Highly Conserved Regions within the Spike Proteins of Human Coronaviruses 229E and NL63 Determine Recognition of Their Respective Cellular Receptors..
H. Hofmann, G. Simmons, A. J. Rennekamp, C. Chaipan, T. Gramberg, E. Heck, M. Geier, A. Wegele, A. Marzi, P. Bates, et al. (2006)
J. Virol.
80, 8639-8652
|Abstract »|Full Text »|PDF »
Human Neutralizing Fab Molecules against Severe Acute Respiratory Syndrome Coronavirus Generated by Phage Display..
X. Kang, B.-a. Yang, Y. Hu, H. Zhao, W. Xiong, Y. Yang, B. Si, and Q. Zhu (2006)
Clin. Vaccine Immunol.
13, 953-957
|Abstract »|Full Text »|PDF »
Conformational States of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Ectodomain.
F. Li, M. Berardi, W. Li, M. Farzan, P. R. Dormitzer, and S. C. Harrison (2006)
J. Virol.
80, 6794-6800
|Abstract »|Full Text »|PDF »
Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody.
P. Prabakaran, J. Gan, Y. Feng, Z. Zhu, V. Choudhry, X. Xiao, X. Ji, and D. S. Dimitrov (2006)
J. Biol. Chem.
281, 15829-15836
|Abstract »|Full Text »|PDF »
Antigenic and Immunogenic Characterization of Recombinant Baculovirus-Expressed Severe Acute Respiratory Syndrome Coronavirus Spike Protein: Implication for Vaccine Design..
Y. He, J. Li, S. Heck, S. Lustigman, and S. Jiang (2006)
J. Virol.
80, 5757-5767
|Abstract »|Full Text »|PDF »
Cross-Neutralization of Human and Palm Civet Severe Acute Respiratory Syndrome Coronaviruses by Antibodies Targeting the Receptor-Binding Domain of Spike Protein.
Y. He, J. Li, W. Li, S. Lustigman, M. Farzan, and S. Jiang (2006)
J. Immunol.
176, 6085-6092
|Abstract »|Full Text »|PDF »
Animal Origins of the Severe Acute Respiratory Syndrome Coronavirus: Insight from ACE2-S-Protein Interactions.
W. Li, S.-K. Wong, F. Li, J. H. Kuhn, I-C. Huang, H. Choe, and M. Farzan (2006)
J. Virol.
80, 4211-4219
|Full Text »|PDF »
Significant Redox Insensitivity of the Functions of the SARS-CoV Spike Glycoprotein: COMPARISON WITH HIV ENVELOPE.
D. Lavillette, R. Barbouche, Y. Yao, B. Boson, F.-L. Cosset, I. M. Jones, and E. Fenouillet (2006)
J. Biol. Chem.
281, 9200-9204
|Abstract »|Full Text »|PDF »
Mucosal Immunization with Surface-Displayed Severe Acute Respiratory Syndrome Coronavirus Spike Protein on Lactobacillus casei Induces Neutralizing Antibodies in Mice..
J.-S. Lee, H. Poo, D. P. Han, S.-P. Hong, K. Kim, M. W. Cho, E. Kim, M.-H. Sung, and C.-J. Kim (2006)
J. Virol.
80, 4079-4087
|Abstract »|Full Text »|PDF »
Defining the Cellular Target(s) of Porcine Reproductive and Respiratory Syndrome Virus Blocking Monoclonal Antibody 7G10.
J.-K. Kim, A.-M. Fahad, K. Shanmukhappa, and S. Kapil (2006)
J. Virol.
80, 689-696
|Abstract »|Full Text »|PDF »